Company / SG&A per Share
Marker Therapeutics, Inc. SG&A per Share History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.25
FY2021
5-year range
$0.22 / $0.60
FY2018-FY2021
Trend
+16.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.60 to $0.25 over the past 3 years.
Based on SEC 10-K filings.
0.25 in FY2021.
Improved from $0.60 to $0.25 over the past 3 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -25.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, sg&a per share increased 16.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.25 | +16.0% |
| FY2019 | $0.22 | -63.7% |
| FY2018 | $0.60 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026